Connect with EKF at AABB 2025 in San Diego, USA. EKF Diagnostics will be exhibiting at the AABB Annual Meeting 2025, taking place 25 - 28 October 2025 at the San Diego Convention Center, San Diego, CA, USA. EKF delivers diagnostic technologies and biotechnology solutions, empowering healthcare and medical providers to make informed clinical decisions through point-of-care testing and life sciences applications. EKF Diagnostics is delighted to announce that EKF will be presenting new data at AABB 2025. Join EKF Diagnostics in the Poster Hall (SDCC Exhibit Hall F-H, AABB Learning Theater) to view: In this study, EKF Diagnostics benchmark the DiaSpect Tm hemoglobin analyzer against HemoCue 301, Hemo Control, and ABL90 Flex - all using venous whole blood. The results show excellent agreement, clinically acceptable biases, and underline DiaSpect Tm's key benefits: rapid results, portability, and ease of use. These attributes make it an excellent option for mobile and decentralized donor screening. You can also visit EKF at Booth #1210 to explore its latest diagnostic solutions that support accurate, reliable, and efficient testing. Some of its featured solutions include: * Hemo Control - A hemoglobin and hematocrit analyzer designed to provide quick lab-quality results from one simple test, enhancing patient care in blood banks, hospitals, and medical offices. * DiaSpect Tm - A hand-held hemoglobin analyzer delivering immediate lab-quality results in just one second, making it a valuable tool for screening and testing, essential for remote or mobile settings. * EKF Link - Explore EKF Link, its versatile software platform that connects point-of-care devices seamlessly to hospital and laboratory IT systems. The 2025 AABB Annual Meeting brings together the latest research and practice-changing resources for the fields of blood and biotherapies. Colleagues from throughout the world attend to connect, network, learn and advance the field. Don't hesitate to contact your EKF Sales representative or email [email protected] to arrange a dedicated meeting. EKF leads the way with cutting-edge point-of-care diagnostic solutions that empower healthcare professionals and patients with rapid, accurate, accessible testing capabilities and results. Its technologies enable informed decision-making, timely interventions, and improved patient outcomes at the point-of-care. EKF Diagnostics look forward to welcoming you to AABB 2025 and exploring how EKF's diagnostic solutions can support your healthcare needs. For specific event enquiries please contact [email protected]. For all other product enquiries, sales enquiries, technical support enquiries or anything else regarding its Point-of-Care, Life Sciences, or Central Laboratory products and services please visit its contact page.

EKF Diagnostics Holdings, the AIM-listed global diagnostics business, has announced the launch of its new Biosen C-Line (Biosen), an advanced version of its industry leading rapid benchtop glucose and lactate analyser.